Remove how-to-patent-in-china
article thumbnail

How to reduce the risk of pharmaceutical patent application in China?

JD Supra Law

As a large pharmaceutical consumer market, China's position in the layout of pharmaceutical patents has been valued. Inventions such as medical use, drug crystalline form and the like, have been paid more attention in the patent layout as playing a great role in continuing the patent protection of the original drug.

article thumbnail

How to smoothly obtain a pharmaceutical patent in China?

JD Supra Law

As a large pharmaceutical consumer market, China's position in the pharmaceutical patents has been valued. Patents such as medical use, drug crystalline form and the like have been paid more attention as they play a great role in continuing the patent protection of the original drug. By: Linda Liu & Partners

Patent 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

IP Protection of NFTs: A Comparative Look at the US and China

IP Tech Blog

The challenge becomes even bigger if NFTs are to be commercialized, exploited, and protected in different jurisdictions and at the same time — particularly when those markets include China, where protection for a foreign NFT creator or exploiter may face unique challenges. Is this the same in the US and China? The United States.

IP 109
article thumbnail

Clean Technologies: Notes from the 5th Annual IP Data & Research Conference

IPilogue

They outlined some of the key challenges SMEs face in participating successfully in the IP ecosystem: Cost and complexity: The cost of acquiring patents and the complexity of the international system deters companies from participating. Trends and Challenges in Canada’s IP Ownership and a Collective’s Role in Addressing these Challenges.

article thumbnail

The annual World Intellectual Property Indicators Report (WIPI) and China’s IP boom

The IPKat

Despite the difficult situation, enterprises are finding opportunities to reach customers in new ways, open up new markets and bring their ideas to the world using IP. Despite the difficult situation, enterprises are finding opportunities to reach customers in new ways, open up new markets and bring their ideas to the world using IP.

article thumbnail

News express: China releases a 15-year blueprint on the development of intellectual property rights (2021–2035)

The IPKat

On 22 September 2021, China released a 15-year plan to develop intellectual property rights (IPR): ‘The Outline of Building a Powerful Intellectual Property Nation’ (2021–2035). See here a Wikipedia page of the five-year plans in China). Invention patents in strategic emerging industries. This post serves as a quick briefing.

article thumbnail

Now Available! Updated Goodwin’s Guide to Biosimilars Litigation and Regulation in the U.S., 2023-2024

LexBlog IP

The BPCIA also introduced a new scheme to resolve patent disputes involving biosimilar products known as the “patent dance.” ” Since the enactment of the BPCIA, the FDA has approved 46 biosimilar products, and, as the market has grown, litigation activity concerning biosimilars has increased rapidly.